
Angel Investor
James Haycock has been an angel investor in the following startups:

Senisca secures £3.7M in funding to revolutionize age-related disease treatment with RNA-based senotherapeutics, paving the way for a groundbreaking approach to healthcare.

Neuronostics raises over £2 million to revolutionize epilepsy diagnosis with pioneering technology, BioEP, receiving further funding to accelerate market entry and seek FDA approval.
James Haycock is an angel investor based in London, in the UK.
Featured Angel Investors